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Chapter 14   
Anticoagulant Rodenticides and Wildlife: 
Concluding Remarks             
Nico W. van den Brink, John E. Elliott, Richard F. Shore, 
and Barnett A. Rattner
Rodents are known to affect human society globally in various adverse ways (Chap. 1). 
Since historic times, they have been vectors for a wide range of human and livestock 
diseases. Almost all agricultural activity worldwide, both past and present, has been 
subject to attack and fouling by rodents, which may therefore threaten our ability to 
feed ourselves.
More recently, rodents have presented new problems, for example by causing 
damage to power supplies and electrical infrastructure, and by colonising (with 
inadvertent help from humans) remote islands and predating the eggs and chicks of 
what are often rare and endemic species of significant conservation value. The over-
all result of this multi-faceted conflict with mankind is a widespread demand for 
continuous control of commensal rodents, and in some cases other species.
Anticoagulant rodenticides (ARs) have been, and currently remain, the corner-
stone of rodent control throughout the world (Chap. 2). Although alternative methods 
exist, they are less effective for control of large scale outbreaks or infestations, such 
as across agricultural areas. Other reasons further explain why ARs have become a 
mainstay of chemical control, and these are related to their mode of toxicity and 
pharmacokinetics. Briefly, AR mode of action (and toxicity) involves binding to vita-
min K epoxide reductase sites, especially in the liver, and preventing the activation of 
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clotting factors, eventually resulting in coagulopathy (Chap. 3). In terms of efficacy 
and safety, there are two important beneficial consequences of this mode of toxicity. 
First, the delayed onset of physiological effects reduces the likelihood that bait shy-
ness will develop. Second, Vitamin K1 is an effective antidote that mitigates the 
action of ARs. Accidental ingestion of ARs by livestock, companion animals, humans 
and wildlife can therefore be simply and effectively treated, a key benefit for poisons 
that are so widely used and potentially available to non-target organisms.
Anticoagulant rodenticides have the potential to harm a wide range of non-target 
species because they affect the blood clotting cascade, a highly conserved physio-
logical mechanism amongst vertebrates. Due to this non-selectivity, their undoubted 
benefits for rodent control have to be balanced against the environmental risks that 
these compounds pose. There has been significant research effort world-wide in the 
last 25 years to better characterise and understand the risks of non-target exposure 
and poisoning. In this book, we have brought together and described the current 
state of understanding of these risks.
Although ARs have been used for decades, pharmacokinetic and toxicokinetic 
data have principally been generated from studies on laboratory mammals and con-
centrated on acute effects associated with lethal coagulopathy (Chaps. 3 and 4). 
There are, therefore, relatively limited laboratory data on other (particularly chronic 
and sub-lethal) effects in wildlife species and there are significant gaps in our 
knowledge that are relevant for assessing risk to wildlife. An important gap is an 
understanding of the cause of the large inter- and intra-species differences in sensi-
tivity to ARs amongst the small number of species that have been tested. It is not 
clear where non-target taxa, that may be at most risk of exposure, are ranked within 
species-sensitivity distributions. Knowledge and understanding of Vitamin K status 
in non-target species as it relates to AR sensitivity, as well as other causal and con-
founding factors affecting sensitivity, are lacking. Ecological risk assessments for 
ARs would be significantly improved with additional knowledge in these areas. 
Other major gaps in knowledge include whether there are AR-mediated sub-lethal 
effects, unrelated to coagulopathy, that are significant (Chap. 3), the extent and 
importance of trans-placental and in ovo transfer of ARs, and the impacts of sequen-
tial exposures to ARs as are known to occur in wildlife.
Although there is much we do not know, it is clear that the pharmacokinetics and 
toxicity of ARs not only make them effective poisoning agents but also fundamen-
tally mediate the comparative risk that different ARs pose to non-target species 
(Chaps. 3 and 4). Studies have shown that second-generation anticoagulant rodenti-
cides (SGARs) are more acutely toxic than first-generation compounds (FGARs), 
although the difference in potency is diminished when exposure is chronic. SGARs 
are also more persistent in body tissues, with two- to five-fold longer hepatic half- 
lives. Differences in acute toxicity among compounds are most likely to affect the 
extent to which primary exposure in non-targets results in mortalities. The prolifera-
tion of SGAR use over FGARs may have increased the risk of primary poisoning 
amongst non-targets in general, and in particular amongst bird species. For exam-
ple, the differences in acute toxicity of some SGARs (e.g., brodifacoum,  difethialone) 
between birds and mammals are modest when compared with the seemingly large 
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differences in toxicity of FGARs between birds and mammals. However, it is the 
enhancements both in acute toxicity and tissue half-life in SGARs that are impor-
tant in determining the extent of secondary exposure and poisoning of predators and 
scavengers, and that helps explain why many secondary exposure and poisoning 
studies have focussed on SGARs.
The focus of this book is specifically about the impacts of ARs on wildlife, and 
the ability to clearly identify AR-mediated effects is fundamental to this topic. The 
mere presence of AR residues in tissues demonstrates exposure, but does not indi-
cate that the animal succumbed from AR-mediated effects. A combined approach of 
clinical investigation, measurement of blood parameters and detection of tissue resi-
dues often can enable unequivocal diagnosis, but there are significant difficulties 
(Chap. 5). Knowledge of the pathophysiology of ARs aids in recognizing ante- mortem 
and post-mortem toxicosis. Ante-mortem symptoms, such as lethargy, subdued 
behaviour and unresponsiveness are generally not very specific. However in combi-
nation with observations on changes in blood parameters, such as increased clotting 
times, diagnosis is far more apparent. Many studies however rely on examination 
not of live animals but on necropsy and measurements of tissue residues in wildlife 
carcasses. Symptoms such as pallor of the mucous membranes (e.g., in oral cavity) 
can be an indicator of toxicosis, as is the presence of signs of haemorrhage. 
Histopathological lesions provide supportive evidence of severe blood loss, haem-
orrhage, or hypoxic damage, but are not solely indicative of AR toxicosis. 
Microscopic evidence of haemorrhage in heart, lung, kidney, liver and skeletal muscle, 
and tissue necrosis have also been reported but their prevalence is not always dose-
related to AR-exposure. Furthermore, differentiating between haemorrhages resulting 
from poisoning as opposed to traumatic injury can be difficult.
Overall, the combining of data obtained through various routes of investigation 
and disciplines (e.g., clinical observation and treatment, pathological evaluation and 
forensics) will help provide the most complete picture of whether AR-mediated 
effects have occurred, but unequivocal diagnosis is difficult (Chap. 5). There are 
likely to be diagnostic errors, especially when only data from macroscopic post- 
mortems are available and when necropsies are conducted by researchers with lim-
ited experience. Assessment of probability of death, when possible, in relation to the 
residues in tissues collected from carcasses, may be a means of assessing overall 
AR-induced mortality in populations (Chaps. 6 and 7). This is hampered by the fact 
that it is unclear whether current reported levels of toxicity are over or under- 
estimates. However, what is more likely to be under-detected, or go completely 
undetected, is if exposure to ARs elicits behavioural changes that predispose ani-
mals to other lethal risks, such as being more easily predated or involved in acci-
dents (e.g., electrocution, vehicular strikes). Quantifying how many individuals 
may be “indirectly” affected in this way is a major challenge.
There have been many wildlife studies in which AR tissue residues (primarily in 
liver) have been the principal measurements recorded (Chap. 6). These investigations 
were conducted to determine the nature and extent of primary and secondary exposure 
and comprise the bulk of all the investigations on ARs in wildlife. They have con-
centrated on exposure rather than effects, probably because of the aforementioned 
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difficulties in diagnosing effects. Such residue measurements provide valuable 
information on exposure, as the long tissue half-lives of SGARs provide an “exposure 
signal” that is integrated over days and months. While liver residues are informative 
of exposure, they are of less value for risk assessment where there is a need to esti-
mate dietary AR concentrations for predators. In such cases, total body concentra-
tions of prey animals are recommended, but data on anticoagulant body burdens in 
non-target (and often even target) prey species are generally lacking.
It is perhaps surprising that there have been comparatively few studies on pri-
mary exposure in wildlife (Chap. 6) compared with the number on secondary expo-
sure. This is despite the fact that primary exposure is likely to result in higher dose 
rates to individuals than secondary exposure and would probably be more likely to 
cause acute mortalities. The studies that have been conducted indicate that the taxa 
most at risk of primary exposure include invertebrates, reptiles, birds and mammals. 
Comparatively little is known about primary exposure and effects in invertebrates, 
reptiles or even birds; hence further investigations are needed. Studies on non-target 
small mammals indicate that there are both key ecological (Chap. 6) and landscape 
(Chap. 8) interactions between bait placement and receptor species that influence 
primary exposure. Typically, it is the more granivorous/herbivorous species that are 
most widely exposed, as the vast majority of AR use involves the application of 
cereal baits. Other types of baits are used in and around buildings, which may result 
in other species being exposed, including more omnivorous and even carnivorous 
species. This may play an important role in more urban areas. Animals foraging 
close to bait stations, typically within 100 metres, are more likely to be exposed to 
ARs, although this distance can be greater for the more mobile rodent and other 
species for example birds, and can depend on habitat configuration. In contrast, 
localised spatial interactions are less important when considering aerial bait appli-
cations, because of the large-scale and relatively indiscriminate nature of bait distri-
bution. However, co-occurrence between non-target animals and AR treatments 
does not mean that exposure to ARs actually occurs because species traits, such as 
dietary and habitat preferences, home range size and mobility, all influence the like-
lihood of exposure. Adoption of a trait-based approach, together with consideration 
of the spatial interactions between the compound and non-target species, are likely 
to both enhance a priori identification of primary exposure risk and help identify 
appropriate mitigation measures. It is notable that studies to date suggest a surpris-
ingly high degree of exposure (as evidenced by tissue residues) in shrews and 
hedgehogs, which are predominantly insectivorous, a trait that would not indicate 
high likelihood of exposure (Chaps. 6). Exposure in shrews and hedgehogs may be 
both primary and secondary through consumption of contaminated insects, and pos-
sibly carrion. It is possible that specialist feeders are more plastic in their diet selec-
tion, and that exposure through multiple pathways is more common for many 
individuals, than is presumed.
Overall, it is evident from a range of studies that primary exposure can lead to 
acute mortalities in non-targets and, in some instances, has caused declines in spe-
cies abundance (Chaps. 6 and 7). Populations are likely to recover partly through 
reduced density-dependent mortality, and such recovery may be relatively rapid in 
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species with high intrinsic rates of reproduction. In non-isolated populations, immi-
gration may also contribute to recovery. However, prolonged or permanent baiting 
can exert a continuous mortality pressure, and may encourage immigration into 
what effectively become ecological sink areas. Further studies are needed to quan-
tify the interaction between baiting practices (e.g., formulation, placement, density 
and especially duration) and population effects. Furthermore, given the unexpected 
high occurrence of residues in shrews and hedgehogs, there is a need to determine 
if small insectivores are particularly susceptible to AR exposure, accumulation or 
effects.
It might be expected that secondary exposure in predators would reflect opportu-
nistic feeding behaviour and the highly variable nature of primary exposure in prey. 
However, the often greater life-span and larger foraging areas of predators com-
pared with prey, coupled with the bioaccumulation of ARs in tissues such as the 
liver, mean that secondary exposure is integrated both temporally and spatially. This 
explains the finding that 58% (2414 out of 4187) of predators analyzed in world-
wide field monitoring studies have AR tissue residues, evidence that secondary 
exposure to ARs in populations of predators is a global phenomenon (Chap. 7). 
Because of the diversity of their prey, not all of which feed on rodenticides, expo-
sure might be expected to be lower in generalist predators than in rodent-specialists. 
A review of the literature indeed suggests that the proportion of animals exposed is 
greatest in mammals that specialize on rodents and less in non-specialist mammals; 
interestingly, this difference between generalists and specialists was not apparent in 
birds. Studies further suggest that the most “at-risk” predators are nocturnal oppor-
tunistic predators for which rodents are a key component of their diet, seasonally or 
year-round. The ecological factors that drive the uptake of ARs in predators and 
likelihood of exposure (Chap. 9) are context specific. They depend on the landscape 
that the predators inhabit and the management of habitats within that landscape. For 
example, there is significant potential for ARs to move into food-chains when they 
are mass-applied to agricultural fields, but predators that consume rats and hunt in 
urban environments, where rodent control is commonplace, may be disproportion-
ately exposed. In general, the likelihood of exposure in predators will vary with the 
scale and duration of bait availability to prey, the proportion of prey exposed, the 
temporal trends in prey density, the foraging tactics of predators, and the propensity 
of poisoned rodents to be captured and consumed.
Diagnosis of lethal secondary poisoning is difficult, as discussed earlier and in 
detail in Chap. 5, and so the extent to which secondary exposure causes mortalities 
in non-target predators is uncertain. Liver AR residues tend to be higher in mam-
mals than birds but it is not clear if this is a reflection of differences in exposure, 
bioaccumulation potential, or toxicity. Detection of elevated residues could indicate 
either higher exposure or tolerance— more sensitive individuals and species may 
die before accumulating high residues, and their carcasses rarely found. Despite 
such difficulties in diagnosing fatalities, there have been studies documenting inci-
dents in which relatively large numbers of individual predators have been identified 
as having been poisoned by ARs (e.g., Chap. 7). Some island eradications have also 
led to AR-mediated population declines of predators; current practices can now 
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involve capture, temporary removal and subsequent re-establishment of “at-risk” 
species. There remains no clear evidence of population declines that can be directly 
attributed to AR poisoning. However, cause-effect relations of chemical exposure 
leading to population declines are difficult to detect, attribute and seemingly rare. It 
is also argued (Chap. 12) that predator populations released from other pressures, 
such as persecution, have rapidly expanded despite their widespread exposure to 
ARs, suggesting that any effects caused by ARs may be small in comparison. The 
extent to which secondary poisonings may cause demographic effects is likely to 
vary among species, and even among populations. However, the global evidence of 
exposure, and the uncertainties about the magnitude and drivers of lethal and sub- 
lethal poisoning, dictate the need for continued AR monitoring in predators. This 
should include monitoring in humans, at least amongst groups that eat large amounts 
of game. Furthermore, the role and consequences of AR use on the top-down regula-
tion of rodent populations by predators should also be taken into account when 
considering AR use.
Another key factor that has affected the interaction between ARs and wildlife is 
intrinsic resistance in target species. The genetic and physiological basis for resis-
tance in target species has been the focus of much study (Chap. 10). The widespread 
replacement of FGARs by SGARs is partly the consequence of the development of 
resistance to FGARs in target species. This deployment of more potent and persis-
tent SGARs has unquestionably increased the risk to wildlife from rodent control. 
There is also a possibility that, because of prolonged exposure, resistant rodent pest 
species may accumulate greater AR total body burdens than non-target (presumably 
more sensitive) species. However, there are relatively few studies on body burdens 
in free-living target species; this remains a knowledge gap. Furthermore, it is likely 
that resistance may have indirect effects by prolonging the duration of control cam-
paigns, and thus extending the window of exposure for non-target species. Clearly, 
there is a need to monitor the onset of resistance in target species and, where 
detected, halt the use of compounds rendered less effective by resistance. The devel-
opment of molecular techniques to detect resistance now makes conducting large 
scale genetic surveillance a reality. Characterisation of the resistance status of 
rodent populations can help guide selection of the most efficacious compounds and 
control methods.
The overall risk that ARs pose to wildlife is evident from the fact that their use is 
now regulated in many countries around the world (Chap. 11). Their continued 
authorisation reflects recognition of the benefits delivered by rodent control, and 
concerns that regulatory action might prevent access to effective rodent control for 
some sectors of society (e.g., lower economic strata) and thus limit associated ben-
efits for health and well-being. While there are alternatives to ARs (Chap. 13) such 
as acute rodenticides (acting more rapidly than ARs; e.g., bromethalin, cholecalcif-
erol, strychnine, zinc phosphide), they can also pose a significant hazard through 
direct consumption by many species, including people (especially children), live-
stock, and pets. Forcing a shift from ARs to other chemistries may simply substitute 
one set of risks for another. Furthermore, while it is generally accepted that 
 contamination of wildlife and adverse effects on individuals are undesirable, and to 
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regulatory standards in principle unacceptable, the lack of clear evidence of long- 
term population-level effects on non-target wildlife raises challenging questions as 
to what level of mitigation is actually appropriate and acceptable (Chap. 13). It is 
perhaps not surprising therefore that the regulatory response to AR use is not uni-
versally agreed upon.
Although application of more stringent risk mitigation measures could pose a 
risk to efficacious rodent control, there are various mitigation measures that are 
reasonable and could be implemented (Chap. 12). Those include such measures as 
bait protection, replacing permanent baiting and its associated constant “leakage” of 
ARs into the environment with pulsed baiting that is initiated at the onset of infesta-
tion, restricting use by non-professionals, and avoiding use in areas of high non- 
target density. Such measures are primarily focused on reducing primary exposure 
to non-targets; however, they are unlikely to be particularly efficacious for species 
that cannot be prevented from accessing baits. This may be circumvented by increas-
ing focus on prevention of the development of local populations and non-chemical 
control of target species, which may decrease the need for chemical control. 
Although reductions in non-target primary exposure would be expected to lead to a 
concomitant reduction in secondary exposure, this may be partly confounded by the 
increased availability of AR-poisoned target rodents to predators and scavengers. 
Reduction in secondary exposure may be improved through incorporation of varied 
chemical control methods along with pest control practices common in integrated 
pest management (IPM). These could include non-chemical control, habitat man-
agement, and, in agricultural habitats, the use of lure crops and supplemental feed-
ing. Use of IPM may not only reduce non-target exposure to AR but also benefit 
resistance management. Barriers to adoption of IPM approaches include the percep-
tion that they do not work, work too slowly or are cumbersome, and are typically 
more laborious, expensive and time consuming than simply relying just on applica-
tion of ARs. Therefore, it is important that the expectations of different stakeholders 
are considered and managed. Users may also need to be incentivised further through 
better communication about the risks to wildlife from ARs and the likelihood of 
resistance in targets that may result from an over-reliance on ARs. However, imme-
diate tangible benefits may also be needed, and one possible option would be to link 
implementation of IPM and/or other mitigation measures to existing agricultural 
practices through the use of financial subsidy and levy schemes.
Finally, it seems appropriate for this book, in which we have focussed on the 
scientific evidence of how ARs affect wildlife, to end by considering key informa-
tion gaps. These are the gaps that need to be filled to gain a better understanding of 
the risk that ARs pose to wildlife and the benefits delivered by mitigation measures 
and IPM. In terms of acute effects, better tools are needed to estimate the extent of 
AR-induced mortality in different wildlife populations. Currently, the bulk of avail-
able data on exposure relates to avian and mammalian predators from predomi-
nantly rural environments, yet we still have a poor ability to estimate how ARs 
affect those populations. Furthermore, although we know that there can be extensive 
sub-lethal exposure of non-target wildlife, we know little about the thresholds (dose 
or residues) that cause coagulopathy, and even less about exposure levels that affect 
14 Anticoagulant Rodenticides and Wildlife: Concluding Remarks
386
survival and reproductive fitness. If we in addition consider exposure scenarios and 
species about which we have less information, there is a real lack of knowledge 
about the extent and importance of exposure in lower vertebrates and invertebrates. 
Better information is also needed on exposure of wildlife in urban habitats where 
there is probably the greatest density and frequency of AR use, both professional 
and amateur. Until these knowledge gaps are better addressed, the discussion over 
the need for, or required extent of, mitigation or other interventions will continue. 
While lack of this information has the potential to paralyse decision-making about 
future interventions, and might be considered a priority, it is interesting to note that 
regulatory action and mitigation is proceeding in many countries (Chaps. 11 and 
12). That is based on the undesirability of and public opposition to existing wide 
scale indiscriminate exposure and the potential loss of wildlife, including species 
that are charismatic and of high conservation value. Given that there is already a 
move towards mitigation and increased regulation, the key research priority may 
ultimately be to address the lack of scientific assessment of the effectiveness of both 
specific AR mitigation measures and of IPM approaches to rodent control. Study 
trials, monitoring and reporting of the effects of different measures on efficacy of 
pest species control, on non-target AR exposure, and on management of resistance, 
are sorely needed. If such knowledge gaps can be filled, it should result in a better 
understanding of the holistic costs and benefits of chemical and non-chemical con-
trol. Ultimately, it will enable us to answer the fundamental questions on how much 
rodent control is warranted, of what type, and what are the direct and indirect con-
sequences of such activities on non-target wildlife.
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